From August 5, 2022 to December 21, 2022, the company has repurchased 1,585,320 shares, representing 0.17% for CNY 200.17 million. With this, the company has completed the repurchase of 1,585,320 shares, representing 0.17% for CNY 200.17 million under the buyback announced on August 6, 2022.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Equities
603392
CNE100004090
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
68.26 CNY | +7.67% | +1.46% | -9.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.14% | 11.1B | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.27% | 29.48B | |
+57.86% | 25.43B | |
-17.69% | 11.49B | |
-43.00% | 11.3B | |
+5.24% | 8.75B | |
-8.42% | 7.99B | |
+2.29% | 7.67B |
- Stock Market
- Equities
- 603392 Stock
- News Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Tranche Update on Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback Plan announced on August 6, 2022.